Preeclampsia could be treated with 'blood filtering' therapy, early study hints

livescience - A blood-filtering therapy for preeclampsia is safe for pregnant patients and their babies, according to a new pilot study.

AI Summary: Early clinical work suggests removing a circulating anti‑angiogenic factor can safely extend pregnancies in severe preeclampsia. Researchers used targeted extracorporeal filtration to lower soluble Fms‑like tyrosine kinase‑1 (sFlt‑1) levels, improving maternal and fetal stability long enough to delay delivery and reduce immediate risks, meriting larger controlled trials.

---

Warning: Undefined variable $thumbnail in /home3/thegood9/public_html/website_70aad9ea/cluster.php on line 61

Related Stories

---

Warning: Undefined variable $top_stories in /home3/thegood9/public_html/website_70aad9ea/cluster.php on line 128

Researchers grow liver tissue in patients' bodies; study now under scrutiny / 6 wks

Engineered esophagus tissue offers new hope for children with absent organs / 2 months

Studies neglect women's experiences in childbirth and breastfeeding research / 15 days

New science pushes erectile disorder treatment beyond Viagra / 4 wks

FDA approves Rocket Pharma gene therapy for ultra‑rare immune disorder / 2 months

Grail’s Galleri blood test misses UK study goal; investor jitters / 3 months

UCLA unveils low-cost blood test to detect multiple cancers from one sample / 7 wks